Lire l'intervention de Jean-Pol Tassin

More documents

Recommendations

Info

17501500125010007505002500Amph.5-HT (% baseline)p-Chloroamph.250200150100500125100755025-40 0 40 80 120 160 2000-40 0 40 80 120 160 200Locomotor activity(¼ turn per 5 min)Locomotor activity(¼ turn per 5 min)125010007505002500Venlafaxine/ClorimipramineACBDacute repeated saline repeated venlafaxine repeated clorimipramineNE (% baseline)
Page 1 and 2: USAGEABUSDEPENDANCE
Page 5 and 6: No predictionReward occurs(No CS)RR
Page 7 and 8: POMPE D’INJECTIONORDINATEURTROUIN
Page 10: CortexPré-FrontalGluNoyauAccumbens
Page 13 and 14: 150100500-40 0 40 80 120 160 200Tem
Page 15 and 16: 150100500-40 0 40 80 120 160 200Tem
Page 17 and 18: CortexPré-FrontalGluNoyauAccumbens
Page 19 and 20: 2500NA (% basal)200015001000Amphét
Page 21 and 22: GABAGluCPFD 1D 2AMPAGABA ANAccGABAG
Page 23: D 1GABAGluCPFD 2α 1b5-HT 2AAMPAGAB
Page 26 and 27: CPFGluNAccGABA5-HT 1A RRD5-HTDAATV5
Page 28 and 29: USAGEJus de pommeDAABUSNA / 5-HTDro
Page 42 and 43: Injection AIGUË Morphine / test Pr
Page 44 and 45: Injections REPETEES Morphine / test
Page 46 and 47: Amph.5-HT (% baseline)1250100075050
Page 48 and 49: 17501500125010007505002500Amph.5-HT
Page 52 and 53: ABSENCE D’EFFET HYPERLOCOMOTEURDE
Page 54 and 55: EFFET HYPERLOCOMOTEUR DE LA NICOTIN
Page 56 and 57: AUTO-ADMINISTRATION DE NICOTINECHEZ
Page 58 and 59: NE (% baseline)12501000750500250Amp
Page 60: PCA15001000500Amph.5-HT (% baseline
Page 63 and 64: PROPOSITIONS ET OBSERVATIONS- L’a
Page 65 and 66: Amph.500400300200100saline + AmphSC
Page 67 and 68: Dopaminergic antagonistsAntipsychot
Page 75 and 76: Locomotor activity(¼ turn / min)50
Page 77 and 78: outon synaptiquerécepteurspré-syn
Page 79 and 80: CONTROL6-OHDALESIONEDAB
Page 83: α1b+/+α1b -/-D-Amph (3 mg/kg, ip)

Lire l'intervention de Jean-Pol Tassin

Create successful ePaper yourself

Delete template?

Save as template?